(Radiopharmaceutical and chemotherapeutic drug technology)

Technical Report · Thu Jan 14 00:00:00 EST 1988

DOI:https://doi.org/10.2172/6808895· OSTI ID:6808895

Srivastava, P C

The purpose was to undertake a TOKTEN Distinguished Scientist Award assignment sponsored by the United Nations Development Programme (UNDP) in cooperation with the Council of Scientific and Industrial Research (CSIR) of India to conduct research in the areas of nucleosides and protein labeling agents at the Central Drug Research Institute (CDRI), Lucknow, and to help research scientists develop chemotherapeutic drugs in India. His work at CDRI consisted of syntheses of imidazole nucleosides, iodination reactions of nucleosides, synthesis of a bifunctional bismaleimide protein labeling agent, coordination of protein labeling studies with the Membrane Biology Group of CDRI, and initiation of several new collaborative research projects at CDRI. In addition, as a part of the CSIR-UNDP, the traveler visited several academic and industrial research institutions in India, delivered five seminars describing various aspects of radiopharmaceutical development at ORNL, and interacted extensively with scientists in India on current drug and radiopharmaceutical develop technologies in India and abroad.

• Research Organization: Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
• Sponsoring Organization: DOE/ER
• DOE Contract Number: AC05-84OR21400
• OSTI ID: 6808895
• Report Number(s): ORNL/FTR-2797; ON: DE90012325
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
CHEMOTHERAPY
DRUGS
SYNTHESIS
PROTEINS
LABELLING
RADIOPHARMACEUTICALS
INDIA
IODINATION
NUCLEAR MEDICINE
NUCLEOSIDES
TRAVEL
ASIA
CHEMICAL REACTIONS
DEVELOPING COUNTRIES
HALOGENATION
LABELLED COMPOUNDS
MEDICINE
NUCLEOTIDES
ORGANIC COMPOUNDS
RIBOSIDES
THERAPY
550604* - Medicine- Unsealed Radionuclides in Therapy- (1980-)